Company Telehealth News (2026)
Launches, partnerships, filings and shutdowns at the companies in our rankings.
Company
Noom buys a 503A pharmacy the week FDA restates compounding limits
Noom closed its purchase of Tailor Made Compounding, a 503A pharmacy licensed in 46 states, the same day the FDA restated its GLP-1 compounding conditions.
Company
Hims & Hers drops compounded GLP-1s as Novo Nordisk drops suit
Hims & Hers will stop advertising compounded GLP-1s and sell branded Ozempic and Wegovy instead. Novo Nordisk dismissed its lawsuit the same day.